Takeda Pharmaceutical Company Limited
GROWTH INHIBITOR
Last updated:
Abstract:
The present invention relates to a method for producing an insulin-producing cell population or a pancreatic .beta. cell population having the reduced number of Ki67-positive cells, comprising treating a population of endocrine progenitor cells or cells at a later stage of differentiation with an FGFR1 inhibitor.
Status:
Application
Type:
Utility
Filling date:
22 Apr 2019
Issue date:
19 Aug 2021